These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. Van Loveren H, Askenase PW. J Immunol; 1984 Nov; 133(5):2397-401. PubMed ID: 6332849 [Abstract] [Full Text] [Related]
3. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity. Ptak W, Bereta M, Ptak M, Askenase PW. J Immunol; 1986 Mar 01; 136(5):1554-63. PubMed ID: 2419404 [Abstract] [Full Text] [Related]
5. Cellular interactions in the adoptive transfer of contact sensitivity: characterization of an antigen-nonspecific Vicia villosa-adherent T cell needed for adoptive transfer into naive recipients. Ptak W, Green DR, Flood P. J Immunol; 1986 Sep 15; 137(6):1822-8. PubMed ID: 2943803 [Abstract] [Full Text] [Related]
6. Isotype-like suppression of T cell-mediated immunity in vivo. II. Suppression of the early component of contact sensitivity by a Ly-2+ T cell-derived suppressor factor that binds to contact sensitivity-initiating, antigen-specific, Ly-1+ T cell-derived factors that are of different antigen specificities. Ptak W, Bereta M, Ptak M, Askenase PW. J Immunol; 1986 Mar 01; 136(5):1564-70. PubMed ID: 2419405 [Abstract] [Full Text] [Related]
13. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses. Miller SD, Butler LD. J Immunol; 1983 Jul 01; 131(1):77-85. PubMed ID: 6190929 [Abstract] [Full Text] [Related]
17. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. Askenase PW, Van Loveren H, Kraeuter-Kops S, Ron Y, Meade R, Theoharides TC, Nordlund JJ, Scovern H, Gerhson MD, Ptak W. J Immunol; 1983 Dec 01; 131(6):2687-94. PubMed ID: 6605986 [Abstract] [Full Text] [Related]
18. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors. Herzog WR, Ferreri NR, Ptak W, Askenase PW. J Immunol; 1989 Nov 15; 143(10):3125-33. PubMed ID: 2478617 [Abstract] [Full Text] [Related]
19. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor. Kops SK, Van Loveren H, Rosenstein RW, Ptak W, Askenase PW. Lab Invest; 1984 Apr 15; 50(4):421-34. PubMed ID: 6608629 [Abstract] [Full Text] [Related]
20. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors. Van Loveren H, Den Otter W, Meade R, Terheggen PM, Askenase PW. J Immunol; 1985 Feb 15; 134(2):1292-9. PubMed ID: 3871209 [Abstract] [Full Text] [Related] Page: [Next] [New Search]